1. Home
  2. NEN vs NKTX Comparison

NEN vs NKTX Comparison

Compare NEN & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

HOLD

Current Price

$56.00

Market Cap

197.0M

Sector

Real Estate

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.35

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEN
NKTX
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
198.2M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NEN
NKTX
Price
$56.00
$2.35
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.33
AVG Volume (30 Days)
487.0
636.3K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
2.71%
N/A
EPS Growth
N/A
11.88
EPS
N/A
N/A
Revenue
$89,196,544.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.68
N/A
Revenue Growth
10.76
N/A
52 Week Low
$55.61
$1.70
52 Week High
$73.50
$3.72

Technical Indicators

Market Signals
Indicator
NEN
NKTX
Relative Strength Index (RSI) 42.00 46.38
Support Level $55.81 $2.32
Resistance Level $60.90 $2.43
Average True Range (ATR) 0.62 0.14
MACD -0.03 0.04
Stochastic Oscillator 12.67 74.71

Price Performance

Historical Comparison
NEN
NKTX

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: